Riboflavin Has Neuroprotective Potential: Focus on Parkinson's Disease and Migraine

Area of Science:

• Neuroscience
• Biochemistry
• Pharmacology

Background:

• Neurological disorders significantly impact patients and societal resources.
• Discovering effective neuroprotective agents is crucial for disease management.
• Riboflavin (vitamin B2) is an underestimated agent with potential neuroprotective properties.

Purpose of the Study:

• To highlight the neuroprotective mechanisms of riboflavin.
• To explore how riboflavin counters shared pathogenic pathways in neurological disorders.
• To emphasize the potential of riboflavin in managing Parkinson's disease and migraine headaches.

Main Methods:

• Review of existing literature on riboflavin's biochemical functions.
• Analysis of shared pathogenesis mechanisms in Parkinson's disease and migraine.
• Correlation of riboflavin's effects with disease-specific pathological pathways.

Main Results:

• Riboflavin ameliorates oxidative stress, mitochondrial dysfunction, neuroinflammation, and glutamate excitotoxicity.
• Riboflavin-dependent enzymes are vital for pyridoxine activation, tryptophan metabolism, and homocysteine regulation.
• Active metabolites like pyridoxal phosphate and kynurenines exhibit independent neuroprotective effects.

Conclusions:

• Riboflavin demonstrates broad neuroprotective potential against mechanisms implicated in Parkinson's disease and migraine.
• Riboflavin influences key pathways including folate and methylation cycles, impacting homocysteine levels.
• Clinical evaluation of riboflavin for Parkinson's disease and migraine is warranted.